Table 4 Univariate and multivariate regression analysis for predicting the risk of death in older patients with COVID-19
From: Clinical characteristics and manifestations in older patients with COVID-19
Univariate | Multivariate | |||
|---|---|---|---|---|
OR (95%CI) | P | OR (95%CI) | P | |
Age (years) | 1.111 (1.069–1.155) | 0.000 | 1.085 (1.017–1.158) | 0.014 |
History of cardiovascular disease | 3.299 (1.665–6.535) | 0.001 | ||
ARDS | 8.888 (4.687–16.853) | 0.000 | 8.576 (3.084–23.850) | 0.000 |
Acute cardiac injury | 22.960 (11.284–46.717) | 0.000 | 3.690 (1.233–11.042) | 0.020 |
Heart failure | 9.583 (4.552–20.178) | 0.000 | 4.782 (1.543–14.817) | 0.007 |
New or worsening arrhythmia | 1.384 (0.722–2.652) | 0.328 | ||
Acute liver injury | 1.915 (0.862–4.253) | 0.111 | ||
Acute kidney injury | 4.084 (1.317–12.661) | 0.015 | ||
Skeletal muscle injury | 10.545 (4.013–27.709) | 0.000 | 7.330 (1.453–36.977) | 0.016 |
Leukocytosis | 10.635 (4.897–23.094) | 0.000 | ||
Lymphopenia | 4.435 (2.427–8.105) | 0.000 | 2.793 (1.030–7.578) | 0.044 |
Hypoalbuminemia | 3.042 (1.124–8.231) | 0.028 | ||
Antiviral therapy | 1.146 (0.244–5.378) | 0.863 | ||
Antibiotic therapy | 7.714 (2.338–25.450) | 0.001 | ||
Glucocorticoids | 3.989 (2.155–7.384) | 0.000 | 3.990 (1.364–11.668) | 0.011 |